Accuray Inc (ARAY)

$ARAY Company destroyed, that's ok, RS, or dilution, etc. SOP for these guys.

$ARAY "Heads up alert! Only three days until Upcoming earnings on Wednesday, 1/28/2026 for $ARAY Bearish (2.5) Accuray Incorporated (NASDAQ: ARAY) has been navigating a challenging landscape, as indicated by recent assessments of its financial performance and strategic initiatives. The company's P/E ratio stands at approximately 15.4, which is above the industry average of around 12, suggesting that it may be overvalued relative to its peers. Furthermore, the company has been struggling with profitability, as evidenced by a reported negative EPS growth over the past five years, indicating that investors have not seen returns during this period. Revenue forecasts remain uncertain, with analysts projecting modest growth as the company embarks on a comprehensive transformation plan aimed at enhancing operational efficiency and profitability. This plan is expected to improve annualized operating profitability by approximately $25 million, which could positively influence future revenue streams. However, the historical performance of Accuray raises concerns, as the stock has not been a favorable investment over the long term, and institutional ownership of 59% suggests that significant decisions are likely influenced by a limited number of stakeholders, potentially constraining broader investor sentiment. In terms of upcoming earnings reports, Accuray is set to release its second quarter fiscal 2026 financial results on February 4, 2026. Analysts are keenly watching this report, particularly in light of the company's strategic transformation efforts. Expectations are tempered, given the historical underperformance and the need for clear signs of improvement in both revenue and profitability metrics. Analyst consensus estimates are cautiously optimistic, but the potential impact on the stock price remains uncertain, especially if results do not meet expectations. Overall, the sector to which Accuray belongs, healthcare technology, has been experiencing varied performance. While some companies are thriving due to advancements in medical technology and increased healthcare spending, Accuray's struggles highlight the competitive pressures and the need for innovation within the sector. Investors should remain vigilant as the company attempts to navigate its transformation and restore confidence among its stakeholders. - Funds were net buyers of $ARAY during the previous reporting quarter. - Funds with large holdings in $ARAY include: - Armistice Capital LLC, MV: $6MM. Fund Rank: 73% www.armisticecapital.com - Acuitas Investments LLC, MV: $4MM. Fund Rank: 58% www.acuitasinvestments.com - DAFNA Capital Management LLC, MV: $2MM. Fund Rank: 74% www.dafnacapital.com - Last 10 days performance: -8% - Last 30 days performance: -9% - Last 90 days performance: -49% Some of the latest news articles: - Title: Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026 Publication Date: 1/21/2026 9:05:00 PM, Source: yahoo URL: https://finance.yahoo.com/news/accuray-report-second-quarter-fiscal-210500292.html?.tsrc=rss - Title: The past five years for Accuray (NASDAQ:ARAY) investors has not been profitable Publication Date: 1/11/2026 1:04:56 PM, Source: yahoo URL: https://finance.yahoo.com/news/past-five-years-accuray-nasdaq-130456847.html?.tsrc=rss - Title: Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth Publication Date: 12/15/2025 10:00:00 PM, Source: yahoo URL: https://finance.yahoo.com/news/accuray-announces-first-phase-comprehensive-220000083.html?.tsrc=rss - Title: Accuray Incorporated (NASDAQ:ARAY) is largely controlled by institutional shareholders who own 59% of the company Publication Date: 12/13/2025 1:37:37 PM, Source: yahoo URL: https://finance.yahoo.com/news/accuray-incorporated-nasdaq-aray-largely-133737577.html?.tsrc=rss Follow us on stocktwits.com for more earnings alerts. Not a financial advice. Not a trading signal."

$ARAY .04-.14

Wall St is expecting -0.11 EPS for $ARAY Q2 [Reporting 02/04 AMC] http://www.estimize.com/intro/aray?chart=historical&metric_name=eps&utm_c

$ARAY just for sell now in Revolut. Bad feelings for a while now.

$ARAY do they have some serious n mighty competitor emerging?

$ARAY Confidence will depend on whether guidance becomes dependable; unit economics must show steady improvement — discipline in guidance could rebuild trust. Until validation appears, volatility remains the default.

$ARAY all too familiar. Drop to .50, reverse split and offering following that, IMHO.

$ARAY Share Price: $0.84 Contract Selected: Jun 18, 2026 $1.0 Calls Buy Zone: $0.09 – $0.11 Target Zone: $0.15 – $0.19 Potential Upside: 69% ROI Time to Expiration: 176 Days | Updates via https://fxcapta.com/stockinfo/

$ARAY 30 million loss last qtr. ? hate to tell you longs and pumpers. This bad boy has to make a BIG cash call. I smell an offering coming not to mention reverse. Careful treading at .90. She’s looking like a .40 spot. Burning cash like Trump and Epsteins Island .40